Form DEFA14A ALLSCRIPTS HEALTHCARE
Veradigm Inc. - common stock (MDRX)
Last veradigm inc. - common stock earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.allscripts.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
MDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDRX alerts
High impacting Veradigm Inc. - common stock news events
Weekly update
A roundup of the hottest topics
MDRX
News
- Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q FilingBusiness Wire
- Electronic Prescribing Market Prospects 2030 [MarketWatch]MarketWatch
- RevSpring and Next Level Medical Now Offering Completely Connected Patient Journey, Including Payments, with Digital Engagement PlatformPR Web
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at Stephens. They set an "equal weight" rating on the stock.MarketBeat
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veradigm (MDRX) Investors with Substantial Losses to Contact Firm, Firm Investigating Admitted Improper Accounting and Possible Securities Law ViolationsGlobeNewswire
MDRX
Earnings
- 11/3/22 - Beat
MDRX
Sec Filings
- 5/26/23 - Form 4
- 5/19/23 - Form 8-K
- 5/11/23 - Form 4
- MDRX's page on the SEC website